Logo image
Back
Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes
Journal article   Open access   Peer reviewed

Variation in Sedative and Analgesic Use During the COVID-19 Pandemic and Associated Outcomes

Justin M. Rucci, Anica C. Law, Scott Bolesta, Emily K. Quinn, Michael A. Garcia, Ognjen Gajic, Karen Boman, Santiago Yus, Valerie M. Goodspeed, Vishakha Kumar, …
CHEST critical care, Vol.2(1), p.100047
03/01/2024
DOI: 10.1016/j.chstcc.2024.100047
PMID: 38576856
url
https://doi.org/10.1016/j.chstcc.2024.100047View
Published (Version of record) Open Access

Abstract

Background: Providing analgesia and sedation is an essential component of caring for many mechanically ventilated patients. The selection of analgesic and sedative medications during the COVID-19 pandemic, and the impact of these sedation practices on patient outcomes, remain incompletely characterized. Research Question: What were the hospital patterns of analgesic and sedative use for patients with COVID-19 who received mechanical ventilation (MV), and what differences in clinical patient outcomes were observed across prevailing sedation practices? Study Design and Methods: We conducted an observational cohort study of hospitalized adults who received MV for COVID-19 from February 2020 through April 2021 within the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) COVID-19 Registry. To describe common sedation practices, we used hierarchical clustering to group hospitals based on the percentage of patients who received various analgesic and sedative medications. We then used multivariable regression models to evaluate the association between hospital analgesia and sedation cluster and duration of MV (with a placement of death [POD] approach to account for competing risks). Results: We identified 1,313 adults across 35 hospitals admitted with COVID-19 who received MV. Two clusters of analgesia and sedation practices were identified. Cluster 1 hospitals generally administered opioids and propofol with occasional use of additional sedatives (eg, benzodiazepines, alpha-agonists, and ketamine); cluster 2 hospitals predominantly used opioids and benzodiazepines without other sedatives. As compared with patients in cluster 2, patients admitted to cluster 1 hospitals underwent a shorter adjusted median duration of MV with POD (β-estimate, –5.9; 95% CI, –11.2 to –0.6; P =.03). Interpretation: Patients who received MV for COVID-19 in hospitals that prioritized opioids and propofol for analgesia and sedation experienced shorter adjusted median duration of MV with POD as compared with patients who received MV in hospitals that primarily used opioids and benzodiazepines.
 acute respiratory failure analgesia COVID-19 mechanical ventilation sedation

Details

Metrics

1 Record Views
Logo image